| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.06.24 | Nurix Therapeutics, Inc.: Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024) | 245 | GlobeNewswire (Europe) | Objective response rate of 69.2% observed in heavily pretreated patient population including patients with BTK inhibitor resistance mutations Clinical responses in CLL patients were rapid and deepening... ► Artikel lesen | |
| 16.06.24 | Regeneron Pharmaceuticals, Inc.: Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma | 379 | GlobeNewswire (Europe) | At 14-months median follow-up in the pivotal trial, 50% of patients achieved a complete response or better and a 71% overall response rate, as presented in an EHA oral presentation and simultaneously... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 5.138 |
| STEYR MOTORS | 2.899 |
| RENK GROUP | 2.680 |
| RHEINMETALL | 2.595 |
| BYD | 2.107 |
| DEUTZ | 1.927 |
| TUI | 1.756 |
| TESLA | 1.661 |
| EVOTEC | 1.414 |
| NEL | 1.217 |
| APPLE | 1.163 |
| ASML | 1.113 |
| BASF | 983 |
| DEUTSCHE BANK | 957 |
| MERCEDES-BENZ | 942 |
| NOVO NORDISK | 925 |
| INFINEON | 917 |
| BAYER | 875 |
| PUMA | 874 |
| VOLKSWAGEN | 867 |
| XIAOMI | 866 |
| THYSSENKRUPP | 865 |
| LVMH | 858 |
| ALLIANZ | 825 |
| PLUG POWER | 815 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
